Cargando…
Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition
The imbalance of bone homeostasis is the root cause of osteoporosis. However current therapeutic approaches mainly focus on either anabolic or catabolic pathways, which often fail to turn the imbalanced bone metabolism around. Herein we reported that a SIRT-1 agonist mediated molecular therapeutic s...
Autores principales: | Zhang, Wei, Zhou, Xingzhi, Hou, Weiduo, Chen, Erman, Ye, Chenyi, Chen, Mo, Lu, Qian, Yu, Xiaohua, Li, Weixu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079176/ https://www.ncbi.nlm.nih.gov/pubmed/35574058 http://dx.doi.org/10.1016/j.bioactmat.2022.04.017 |
Ejemplares similares
-
Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss
por: Hou, Weiduo, et al.
Publicado: (2022) -
Upregulation of Parkin Accelerates Osteoblastic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and Bone Regeneration by Enhancing Autophagy and β-Catenin Signaling
por: Zhang, Wei, et al.
Publicado: (2020) -
Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells
por: Hou, Weiduo, et al.
Publicado: (2019) -
Knockdown of FOXA2 enhances the osteogenic differentiation of bone marrow-derived mesenchymal stem cells partly via activation of the ERK signalling pathway
por: Ye, Chenyi, et al.
Publicado: (2018) -
IGFBP7 acts as a negative regulator of RANKL‐induced osteoclastogenesis and oestrogen deficiency‐induced bone loss
por: Ye, Chenyi, et al.
Publicado: (2019)